USCOM LIMITED — Investor Presentation 2017

Aug 8, 2017

ASX MEDIA RELEASE

New USCOM 1A digital connectivity feature released

SYDNEY, Australia, Wednesday 9[th] August 2017: Uscom Limited (ASX code: UCM) (the Company or Uscom ) a cardiovascular and pulmonary medical device company, today announced the availability of a digital connectivity enhancement for the USCOM 1A Cardiac Output Monitor. This technical feature which includes software and hardware developments allows wireless connectivity to remote digital medical record systems and telemetric transfer of medical examination data.

The digital wireless connectivity feature allows for remote connection to most electronic medical record systems and simplifies the wireless transfer of USCOM 1A examination data to a central medical records archiving system. The USCOM 1A uses the Health Level 7 (HL7) standards to provide an interface to Hospital Information Systems that can share and manage Electronic Medical Records. HL7 is an international standard for transfer of clinical data between devices and healthcare applications. The implementation of HL7 is fundamental for future market segments involving remote monitoring and cloud based analysis and patient diagnosis. In the US, China and much of Asia, the connectivity option is a prerequisite for tendering for medical device contracts, as electronic medical records become best practice. The feature is a technically complex hardware and software upgrade for the USCOM 1A and has been a significant investment and commitment for Uscom and the Uscom Engineers to develop and test.

The Uscom SprioSonic range of products also supports digital connectivity to medical record systems via the SpiroReporter application that connects to the SpiroSonic devices. The Uscom BP+ connects to the BP+ Reporter to provide a medical record storage system.

Executive Chairman of Uscom, Associate Professor Rob Phillips said “ Uscom is establishing itself as a digital medical device specialist. We believe our future is firmly in premium quality non-invasive front end sensors connected to telemetric central archiving and analysis software stored on central servers or in the cloud. This creates great cost effective clinical care as patients can be examined and treated at home, thus reducing hospitalisation and acute medical presentations. Our SpiroSonic devices are sector leading in digital connectivity and are designed for wireless and remote connection to our SpirorReporter software. These devices are already being used by innovators in digital pulmonary health care in the US, and in research applications in Spain and France. The HL7 wireless feature will be vital for our renewed shift to the US market later in the year.”

Uscom Limited (ABN 35 091 028 090) Suite 1, Level 7 10 Loftus Street, Sydney NSW 2000 Australia T: +612 9247 4144 E: info@uscom.com.au W: www.uscom.com.au

ASX MEDIA RELEASE

About Uscom

Uscom Limited (UCM) : An ASX listed innovative medical technology company specialising in development and marketing of premium non-invasive cardiovascular and pulmonary medical devices. Uscom has a mission to demonstrate leadership in science and create noninvasive devices that assist clinicians improve clinical outcomes. Uscom has three practice leading suites of devices in the field of cardiac, vascular and pulmonary monitoring; the USCOM 1A advanced haemodynamic monitor, Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. Uscom devices are premium resolution, noninvasive devices which deploy innovative and practice leading technologies approved or submitted for FDA, CE, CFDA and TGA regulatory approval and marketing into global distribution networks.

The USCOM 1A : A simple to use, cost-effective and non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The USCOM 1A device has major applications in Paediatrics, Emergency, Intensive Care Medicine and Anaesthesia, and is the device of choice for management of adult and paediatric sepsis, hypertension, heart failure and for the guidance of fluid, inotropes and vasoactive cardiovascular therapy.

The Uscom BP+ : A supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm, information only previously available using invasive cardiac catheterisation. The Uscom BP+ replaces conventional and more widespread sub-systolic blood pressure monitors, and is the emerging standard of care measurement in hypertension, heart failure and vascular health. The Uscom BP+ provides a highly accurate and repeatable measurement of central and brachial blood pressure and pulse pressure waveforms using a familiar upper arm cuff. The BP+ is simple to use and requires no complex training with applications in hypertension and pre-eclampsia, heart failure, intensive care, general practice and home care. The Uscom BP+ is supported by the proprietary BP+ Reporter , an innovative stand alone software solution that provides a digital platform to archive patient examinations and images, trend measure progress over time, analyse pulse pressure waves and generate summary reports.

Uscom SpiroSonic digital multi-path ultrasonic spirometers : High fidelity, digital, pulmonary function testing devices based on multi path ultrasound technology. They require no calibration, are simple to disinfect, and are simple and accurate to use providing research quality pulmonary function testing in small hand held devices that can be used in research, clinical and home care environments. The devices can be coupled with mobile phone applications and proprietary SpiroSonic software platforms with wireless interfacing to provide remote telemonitoring of pulmonary disease. The devices are specialised for assessment of COPD, sleep disordered breathing, asthma, industrial lung disease and monitoring of pulmonary therapeutic compliance. The SpiroSonic devices are supported by the proprietary SpiroReporter , an innovative stand alone software solution that provides a digital platform to archive patient examinations and images, trend measure progress over time, analyse spirometry outputs and generate summary reports.

For more information, please visit: www.uscom.com.au

Uscom Contacts

Rob Phillips Executive Chairman rob@uscom.com.au

Brett Crowley Company Secretary secretary@uscom.com.au

Uscom Limited (ABN 35 091 028 090) Suite 1, Level 7 10 Loftus Street, Sydney NSW 2000 Australia T: +612 9247 4144 E: info@uscom.com.au W: www.uscom.com.au